查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768729

全球肝癌诊断市场

Liver Cancer Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 275 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球肝癌诊断市场规模将达 220 亿美元

全球肝癌诊断市场规模预计在2024年为143亿美元，预计到2030年将达到220亿美元，2024年至2030年的复合年增长率为7.4%。临床检测是本报告分析的细分市场之一，预计其复合年增长率为8.4%，到分析期结束时规模将达到98亿美元。影像诊断细分市场在分析期间内的复合年增长率预计为7.5%。

美国市场预计将达到 37 亿美元，中国市场复合年增长率将达到 11.1%

美国肝癌诊断市场规模预计2024年达到37亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到53亿美元，在2024-2030年的分析期间内，复合年增长率为11.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.9%和6.9%。在欧洲，预计德国市场的复合年增长率为4.7%。

全球肝癌诊断市场—主要趋势与驱动因素摘要

如何促进肝癌的早期发现与治疗？

肝癌诊断技术正在快速发展，提高了我们在早期发现肝癌的能力，因为早期治疗方案更有效。肝癌的诊断工具包括超音波、电脑断层扫描 (CT) 和磁振造影(MRI) 等影像技术，以及用于测量甲胎蛋白 (AFP) 等生物标记的血液检测。早期发现至关重要，因为肝癌通常进展缓慢，直到晚期才出现明显症状。由于肝炎感染、饮酒和非酒精性脂肪性肝病 (NAFLD) 等因素导致全球肝癌发病率上升，对先进诊断工具的需求也日益增长。

哪些技术创新正在塑造肝癌诊断市场？

诊断技术的创新正在改变肝癌检测的格局。液态切片是一种分析血液中循环性肿瘤细胞(CTC) 和 DNA 的非侵入性技术，正成为检测肝癌和监测其进展的新兴工具。基因组分析和次世代定序(NGS) 也被整合到肝癌诊断中，以识别可指南个人化治疗策略的特定基因突变。此外，人工智慧 (AI) 和机器学习的进步正在透过增强扫描判读能力和识别传统方法难以检测的早期肿瘤来提高肝癌成像的准确性。

市场区隔将如何定义肝癌诊断的成长？

相关技术包括诊断成像、液态切片和生物标记检测，其中诊断成像占据最大份额，因为它广泛应用于常规筛检。应用涵盖早期检测、诊断和监测，其中早期检测需求巨大，因为医疗保健提供者专注于透过及时干预来提高生存率。终端用户包括医院、诊断实验室和研究机构，其中医院是主要细分市场，因为医院的肝癌筛检和治疗计划量很大。从地理来看，由于中国和日本等国家肝癌发生率高，亚太地区的市场正在迅速扩张。

推动肝癌诊断市场成长的因素有哪些？

肝癌诊断市场的成长受到多种因素的推动，包括肝癌发病率的上升、诊断技术的进步以及人们对早期诊断意识的不断增强。全球肝癌发生率的上升，尤其是在肝炎感染率高的地区，推动了对更准确、更方便的诊断工具的需求。液态切片和人工智慧成像诊断等技术的进步提高了早期检测的准确性，从而实现了更个人化的治疗方法。此外，政府推动癌症筛检和早期诊断的措施也促进了先进诊断工具的普及，进一步推动了市场的成长。

部分

诊断技术（实验室检测、影像、内视镜检查、切片检查和其他诊断技术）、最终用户（医院和诊断实验室、学术和研究机构以及其他最终用户）

受访公司范例

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics USA Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

人工智慧集成

利用检验的专家内容和 AI 工具转变您的市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP22166

Global Liver Cancer Diagnostics Market to Reach US$22.0 Billion by 2030

The global market for Liver Cancer Diagnostics estimated at US$14.3 Billion in the year 2024, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Imaging segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 11.1% CAGR

The Liver Cancer Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Liver Cancer Diagnostics Market - Key Trends and Drivers Summarized

How Is Liver Cancer Diagnostics Advancing Early Detection and Treatment?

Liver cancer diagnostics are undergoing rapid advancements, improving the ability to detect liver cancer at earlier stages when treatment options are more effective. Diagnostic tools for liver cancer include imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), as well as blood tests that measure biomarkers like alpha-fetoprotein (AFP). Early detection is crucial in liver cancer, as the disease often progresses silently with few symptoms until it reaches advanced stages. With rising global rates of liver cancer due to factors such as hepatitis infections, alcohol consumption, and non-alcoholic fatty liver disease (NAFLD), the demand for advanced diagnostic tools is growing.

What Technological Innovations Are Shaping the Liver Cancer Diagnostics Market?

Innovations in diagnostic technologies are transforming the landscape of liver cancer detection. Liquid biopsy, a non-invasive technique that analyzes circulating tumor cells (CTCs) and DNA in the blood, is emerging as a promising tool for detecting liver cancer and monitoring its progression. Genomic profiling and next-generation sequencing (NGS) are also being integrated into liver cancer diagnostics to identify specific genetic mutations that can guide personalized treatment strategies. Additionally, advances in artificial intelligence (AI) and machine learning are improving the accuracy of liver cancer imaging by enhancing the interpretation of scans and identifying early-stage tumors that may be difficult to detect through traditional methods.

How Do Market Segments Define the Growth of Liver Cancer Diagnostics?

Technologies include imaging, liquid biopsy, and biomarker testing, with imaging representing the largest segment due to its widespread use in routine screenings. Applications span early detection, diagnosis, and monitoring, with early detection driving significant demand as healthcare providers focus on improving survival rates through timely intervention. End-users include hospitals, diagnostic laboratories, and research institutions, with hospitals being the primary segment due to the high volume of liver cancer screenings and treatment planning. Geographically, the market is expanding rapidly in Asia-Pacific due to the high prevalence of liver cancer in countries such as China and Japan.

What Factors Are Driving the Growth in the Liver Cancer Diagnostics Market?

The growth in the liver cancer diagnostics market is driven by several factors, including the rising incidence of liver cancer, advancements in diagnostic technologies, and increasing awareness of early detection. As liver cancer rates climb globally, particularly in regions with high hepatitis infection rates, the need for more accurate and accessible diagnostic tools is intensifying. Technological advancements, such as liquid biopsy and AI-enhanced imaging, are improving the precision of early detection, enabling more personalized treatment approaches. Furthermore, government initiatives to promote cancer screenings and early diagnosis are encouraging the adoption of advanced diagnostic tools, further boosting market growth.

SCOPE OF STUDY:

The report analyzes the Liver Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Diagnosis Technique (Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques); End-Use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics U.S.A. Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Liver Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Liver Cancer and Increasing Awareness Drive Growth in Liver Cancer Diagnostics Market
    • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Business Case for Adoption
    • Growing Use of Liquid Biopsies and Biomarker-Based Diagnostics Expands Addressable Market
    • Expansion of Early Detection Programs Fuels Demand for Liver Cancer Diagnostics
    • Increasing Adoption of Non-Invasive Diagnostic Techniques Drives Market Growth
    • Technological Innovations in Next-Generation Sequencing (NGS) Propel Market Growth in Liver Cancer Diagnostics
    • Focus on Enhancing Accuracy and Reducing False Positives Strengthens Demand for Advanced Diagnostic Solutions
    • Growing Use of AI and Machine Learning in Diagnostic Imaging Expands Market Opportunities
    • Rising Demand for Personalized Medicine and Targeted Therapies Fuels Growth in Liver Cancer Diagnostics
    • Technological Advancements in Liquid Biopsy Assays for Early-Stage Detection Propel Market Growth
    • Growing Adoption of Companion Diagnostics in Liver Cancer Treatment Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Diagnosis Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Liver Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION